These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18518837)

  • 1. The relevance of animal models for aerosol studies.
    Phalen RF; Oldham MJ; Wolff RK
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):113-24. PubMed ID: 18518837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric in vitro and in silico models of deposition via oral and nasal inhalation.
    Carrigy NB; Ruzycki CA; Golshahi L; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):149-69. PubMed ID: 24870701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles.
    Oberdorster G
    Inhal Toxicol; 1996; 8 Suppl():73-89. PubMed ID: 11542496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inspiratory and expiratory aerosol deposition in the upper airway.
    Verbanck S; Kalsi HS; Biddiscombe MF; Agnihotri V; Belkassem B; Lacor C; Usmani OS
    Inhal Toxicol; 2011 Feb; 23(2):104-11. PubMed ID: 21309663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of particle size differences between animal studies and human workplace aerosols for deriving exposure limit values.
    Oller AR; Oberdörster G
    Regul Toxicol Pharmacol; 2010; 57(2-3):181-94. PubMed ID: 20172011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining the basic characteristics of aerosols suitable for studies of deposition in the respiratory tract.
    Legáth L; Naus A; Halík J
    J Hyg Epidemiol Microbiol Immunol; 1988; 32(3):287-97. PubMed ID: 3198910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of pulmonary diseases on the fate of inhaled medicines--a review.
    Wang YB; Watts AB; Peters JI; Williams RO
    Int J Pharm; 2014 Jan; 461(1-2):112-28. PubMed ID: 24291124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanisms of the therapeutic and damaging (side effects) actions of inhalation aerosol therapy].
    Pilipchuk NS; Kliachkin LM; Protsiuk RG
    Vopr Kurortol Fizioter Lech Fiz Kult; 1989; (1):21-4. PubMed ID: 2652880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols.
    Byron PR; Hindle M; Lange CF; Longest PW; McRobbie D; Oldham MJ; Olsson B; Thiel CG; Wachtel H; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S59-69. PubMed ID: 21133801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights on animal models to investigate inhalation therapy: Relevance for biotherapeutics.
    Guillon A; Sécher T; Dailey LA; Vecellio L; de Monte M; Si-Tahar M; Diot P; Page CP; Heuzé-Vourc'h N
    Int J Pharm; 2018 Jan; 536(1):116-126. PubMed ID: 29180257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetry considerations for animal aerosol inhalation studies.
    Phalen RF; Mendez LB
    Biomarkers; 2009 Jul; 14 Suppl 1(Suppl 1):63-6. PubMed ID: 19604062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled aerosol particle dosimetry in mice: a review.
    Méndez LB; Gookin G; Phalen RF
    Inhal Toxicol; 2010 Oct; 22(12):1032-7. PubMed ID: 20879957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symposium Summary: "Breathe In, Breathe Out, Its Easy: What You Need to Know About Developing Inhaled Drugs".
    Tepper JS; Kuehl PJ; Cracknell S; Nikula KJ; Pei L; Blanchard JD
    Int J Toxicol; 2016 Jul; 35(4):376-92. PubMed ID: 26857693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted drug-aerosol delivery in the human respiratory system.
    Kleinstreuer C; Zhang Z; Donohue JF
    Annu Rev Biomed Eng; 2008; 10():195-220. PubMed ID: 18412536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interspecies comparisons of lung responses to inhaled particles and gases.
    Warheit DB
    Crit Rev Toxicol; 1989; 20(1):1-29. PubMed ID: 2673290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Particle size-dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model.
    Cassee FR; Muijser H; Duistermaat E; Freijer JJ; Geerse KB; Marijnissen JC; Arts JH
    Arch Toxicol; 2002 Jun; 76(5-6):277-86. PubMed ID: 12107645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the deposition of inhaled particles.
    Yeh HC; Phalen RF; Raabe OG
    Environ Health Perspect; 1976 Jun; 15():147-56. PubMed ID: 1001293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in aerosol dosimetry.
    Phalen RF; Mendez LB; Oldham MJ
    Inhal Toxicol; 2010 Dec; 22 Suppl 2():6-14. PubMed ID: 20939685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement techniques for respiratory tract deposition of airborne nanoparticles: a critical review.
    Löndahl J; Möller W; Pagels JH; Kreyling WG; Swietlicki E; Schmid O
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):229-54. PubMed ID: 24151837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.